These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

919 related articles for article (PubMed ID: 21835642)

  • 1. Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.
    Pychyńska-Pokorska M; Pągowska-Klimek I; Krajewski W; Moll JJ
    J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):987-94. PubMed ID: 21835642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant factor VIIa (NovoSeven) as a hemostatic agent after surgery for congenital heart disease.
    Razon Y; Erez E; Vidne B; Birk E; Katz J; Tamari H; Dagan O
    Paediatr Anaesth; 2005 Mar; 15(3):235-40. PubMed ID: 15725322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant activated factor VII for hemorrhage after pediatric cardiac surgery.
    Singh SP; Chauhan S; Choudhary M; Vasdev S; Talwar S
    Asian Cardiovasc Thorac Ann; 2012 Feb; 20(1):19-23. PubMed ID: 22371937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant activated factor VII following pediatric cardiac surgery.
    Kylasam S; Mos K; Fijtin S; Webster B; Chard R; Egan J
    J Intensive Care Med; 2009; 24(2):116-21. PubMed ID: 19188273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor VII for excessive bleeding following congenital heart disease surgery.
    Changlani DK; Devendaran V; Murmu UC; Ganesan S; Varghese R; Kumar RS
    Asian Cardiovasc Thorac Ann; 2012 Apr; 20(2):120-5. PubMed ID: 22499956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant factor seven therapy for postoperative bleeding in neonatal and pediatric cardiac surgery.
    Agarwal HS; Bennett JE; Churchwell KB; Christian KG; Drinkwater DC; He Y; Taylor MB
    Ann Thorac Surg; 2007 Jul; 84(1):161-8. PubMed ID: 17588404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of recombinant coagulation factor VIIa in uncontrolled postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.
    Pychyńska-Pokorska M; Moll JJ; Krajewski W; Jarosik P
    Pediatr Crit Care Med; 2004 May; 5(3):246-50. PubMed ID: 15115562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombotic risk of recombinant factor seven in pediatric cardiac surgery: a single institution experience.
    Karsies TJ; Nicol KK; Galantowicz ME; Stephens JA; Kerlin BA
    Ann Thorac Surg; 2010 Feb; 89(2):570-6. PubMed ID: 20103344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant factor VII for severe bleeding during extracorporeal membrane oxygenation following open heart surgery.
    Wittenstein B; Ng C; Ravn H; Goldman A
    Pediatr Crit Care Med; 2005 Jul; 6(4):473-6. PubMed ID: 15982438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant activated factor VII in cardiac surgery: single-center experience.
    Singh SP; Chauhan S; Choudhury M; Malik V; Choudhary SK
    Asian Cardiovasc Thorac Ann; 2014 Feb; 22(2):148-54. PubMed ID: 24585784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Change of coagulation after NovoSeven® use for bleeding during cardiac surgery.
    Tomita E; Takase H; Tajima K; Suematsu Y
    Asian Cardiovasc Thorac Ann; 2017 Feb; 25(2):99-104. PubMed ID: 28114794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant activated factor VII in cardiac surgery: experience from the Australian and New Zealand Haemostasis Registry.
    Dunkley S; Phillips L; McCall P; Brereton J; Lindeman R; Jankelowitz G; Cameron P
    Ann Thorac Surg; 2008 Mar; 85(3):836-44. PubMed ID: 18291152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder.
    Yilmaz D; Karapinar B; Balkan C; Akisü M; Kavakli K
    Pediatr Hematol Oncol; 2008 Jun; 25(4):301-11. PubMed ID: 18484474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of the off-label use of recombinant activated factor VII in pediatric cardiac surgery patients.
    Guzzetta NA; Russell IA; Williams GD
    Anesth Analg; 2012 Aug; 115(2):364-78. PubMed ID: 22652310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New possibilities in the postoperative measures to prevent bleeding in cardiac surgery. Will the recombinant activated factor VII improve surgical results?].
    Skalski JH; Czapla J; Nadziakiewicz P; Kaczmarski J; Zembala M
    Przegl Lek; 2002; 59(11):941-5. PubMed ID: 12715727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors.
    Santagostino E; Morfini M; Rocino A; Baudo F; Scaraggi FA; Gringeri A
    Thromb Haemost; 2001 Oct; 86(4):954-8. PubMed ID: 11686352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coagulation considerations for infants and children undergoing cardiopulmonary bypass.
    Eaton MP; Iannoli EM
    Paediatr Anaesth; 2011 Jan; 21(1):31-42. PubMed ID: 21155925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of recombinant activated Factor VII for refractory after lung transplant bleeding as an effective strategy to restrict blood transfusion and associated complications.
    Bhaskar B; Zeigenfuss M; Choudhary J; Fraser JF
    Transfusion; 2013 Apr; 53(4):798-804. PubMed ID: 22845023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant activated factor VIIa in uncontrolled bleeding: a haemostasis laboratory study in non-haemophilia patients.
    Brandsborg S; Sørensen B; Poulsen LH; Ingerslev J
    Blood Coagul Fibrinolysis; 2006 Jun; 17(4):241-9. PubMed ID: 16651865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated recombinant factor VII for refractory bleeding during extracorporeal membrane oxygenation.
    Niebler RA; Punzalan RC; Marchan M; Lankiewicz MW
    Pediatr Crit Care Med; 2010 Jan; 11(1):98-102. PubMed ID: 19561557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.